From: "Nola Wolfe" <effectiveness'sbreach's@aap.nl>
To: alsa-devel@lists.sf.net
Subject: {subj190107}
Date: Fri, 19 Jan 2007 12:47:30 -0120 [thread overview]
Message-ID: <01c73bc7$fb5faab0$6c822ecf@effectiveness'sbreach's> (raw)
No more bankrupts or shit companies.
Look at charts and ask your adviser about:
Ventana Medical Systems
Ventana Receives FDA Approval on Pathway
Thursday January 18, 10:08 am ET
Ventana Medical Systems Receives FDA Approval for Breast Cancer Detection Test
TUCSON, Ariz. (AP) -- Ventana Medical Systems Inc., a maker of tissue and slide preparation systems used in drug development, said Wednesday it received Food and Drug Administration approval on a new antibody.
The company received the approval for its Pathway Her-2/neu (4B5) Rabbit Monoclonal Antibody as an aid in assessing breast cancer patients being considered for treatment with Herceptin. It is also approved for use on the Ventana Image Analysis System.
Herceptin is a cancer treatment made by Genentech Inc. It targets HER-2, which causes breast cancer cells to grow more rapidly. The approved Pathway antibody is intended to detect the presence of the HER-2 antigen.
Get in before most investors hear about this awesome news! VMSI has just made an announcement which, once the investment community hears about it, is going to send the issue flying! Read on to find why we are so excited!
-------------------------------------------------------------------------
Take Surveys. Earn Cash. Influence the Future of IT
Join SourceForge.net's Techsay panel and you'll get the chance to share your
opinions on IT & business topics through brief surveys - and earn cash
http://www.techsay.com/default.php?page=join.php&p=sourceforge&CID=DEVDEV
next reply other threads:[~2007-01-19 14:07 UTC|newest]
Thread overview: 2+ messages / expand[flat|nested] mbox.gz Atom feed top
2007-01-19 14:07 Nola Wolfe [this message]
-- strict thread matches above, loose matches on Subject: below --
2007-01-19 7:36 {subj190107} Mildred Sharpe
Reply instructions:
You may reply publicly to this message via plain-text email
using any one of the following methods:
* Save the following mbox file, import it into your mail client,
and reply-to-all from there: mbox
Avoid top-posting and favor interleaved quoting:
https://en.wikipedia.org/wiki/Posting_style#Interleaved_style
* Reply using the --to, --cc, and --in-reply-to
switches of git-send-email(1):
git send-email \
--in-reply-to='01c73bc7$fb5faab0$6c822ecf@effectiveness'\''sbreach'\''s' \
--to=effectiveness'sbreach's@aap.nl \
--cc=alsa-devel@lists.sf.net \
/path/to/YOUR_REPLY
https://kernel.org/pub/software/scm/git/docs/git-send-email.html
* If your mail client supports setting the In-Reply-To header
via mailto: links, try the mailto: link
Be sure your reply has a Subject: header at the top and a blank line
before the message body.
This is an external index of several public inboxes,
see mirroring instructions on how to clone and mirror
all data and code used by this external index.